S. 316 (110th): Preserve Access to Affordable Generics Act

Introduced:

Jan 17, 2007
110th Congress, 2007–2009

Status:
Died in a previous Congress

This bill was introduced on February 27, 2007, in a previous session of Congress, but was not enacted.

Sponsor:

Herbert “Herb” Kohl

Senator from Wisconsin

Democrat

Text:

Read Text »
Last Updated: Feb 27, 2007
Length: 12 pages

About the bill

Full Title

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

The bill’s title was written by its sponsor.

Read CRS Summary >

History

Jan 17, 2007
 
Introduced

This is the first step in the legislative process.

Feb 27, 2007
 
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Details

Cosponsors
10 cosponsors (9D, 1R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 3582 (109th) was a previous version of this bill.

Referred to Committee
Last Action: Jun 27, 2006

S. 369 (111th) was a re-introduction of this bill in a later Congress.

Reported by Committee
Last Action: Oct 15, 2009

Search for similar bills.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: